Injectable disease modifying agents in multiple sclerosis: pattern of medication use and clinical effectiveness

The objective of this study was to assess long-term use, adherence and efficacy of injectable disease modifying agents (DMAs). Multiple Sclerosis (MS) patients diagnosed during 2002-2010 with early treatment start and at least one year in first choice medication were included in a large university d...

Full description

Saved in:
Bibliographic Details
Main Authors: Elina Järvinen (Author), Markus Holmberg (Author), Marja-Liisa Sumelahti (Author)
Format: Book
Published: MDPI AG, 2016-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available